BDBM489624 (R)-1-(4-(8-amino- 2,2,4-trifluoro- [1,3]dioxolo[4,5-g]- quinazolin-6-yl)- piperazin-1-yl)-3- (ethylamino)-3-(4- fluorophenyl)propan- 1-one::US10961252, Cmp No. 12::US11248000, Cmp No. 12

SMILES CCN[C@H](CC(=O)N1CCN(CC1)c1nc(N)c2cc3OC(F)(F)Oc3c(F)c2n1)c1ccc(F)cc1

InChI Key InChIKey=IVWXLWQYAJZUHD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 489624   

TargetComplement factor B(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489624(US10961252, Cmp No. 12 | (R)-1-(4-(8-amino- 2,2,4-...)
Affinity DataIC50: 5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2021
Entry Details
US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489624(US10961252, Cmp No. 12 | (R)-1-(4-(8-amino- 2,2,4-...)
Affinity DataIC50: 5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent